Position in MGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,305,425
+$5,696,272 QoQ
Shares Held
2,527,829
+152.9% QoQ
Ownership
3.98%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. MGNX ranks #85 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in MGNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,305,425 | 2,527,829 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,609,153 | 999,474 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $734,312 | 437,091 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $492,818 | 407,288 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $831,720 | 654,898 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,797,421 | 860,745 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,906,284 | 883,369 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,201,970 | 1,223,993 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $196,703 | 13,363 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $491,226 | 51,063 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $244,943 | 52,563 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,656,584 | 309,642 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,873,843 | 679,755 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,706,011 | 701,343 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,362,143 | 393,683 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,928,072 | 992,567 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,177,714 | 360,694 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $251,150 | 15,648 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $1,421,306 | 44,625 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,939,064 | 128,568 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,124,257 | 163,726 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,643,151 | 166,302 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $483,286 | 83,039 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||